Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Netupitant in Overactive Bladder: Randomized Phase 2 Dose-Ranging Trial
2008-003190-41Phase 2Completed
- Sponsor
- Helsinn
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of netupitant in overactive bladder (OAB) (4 arms), sponsored by Helsinn. Primary endpoint: Percentage change from baseline in average number of daily micturitions. Started Jul 2008; status: completed.
02
Drugs
netupitant
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on 2008-003190-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003190-41.